ArticleJournal of clinical medicine research2019

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series.

Satoshi Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.